In vitro evaluation of a new viscoelastometry-based point-of-care analyzer
- PMID: 38566492
- DOI: 10.1111/trf.17808
In vitro evaluation of a new viscoelastometry-based point-of-care analyzer
Abstract
Introduction: The VCM is a point-of-care analyzer using a new viscoelastometry technique for rapid assessment of hemostasis on fresh whole blood. Its characteristics would make it suitable for use in austere environments. The purpose of this study was to evaluate the VCM in terms of repeatability, reproducibility and interanalyzer correlation, reference values in our population, correlation with standard coagulation assays and platelet count, correlation with the TEG5000 analyzer and resistance to stress conditions mimicking an austere environment.
Methods: Repeatability, reproducibility, and interanalyzer correlation were performed on quality control samples (n = 10). Reference values were determined from blood donor samples (n = 60). Correlations with standard biological assays were assessed from ICU patients (n = 30) and blood donors (n = 60) samples. Correlation with the TEG5000 was assessed from blood donor samples. Evaluation of vibration resistance was performed on blood donor (n = 5) and quality control (n = 5) samples.
Results: The CVs for repeatability and reproducibility ranged from 0% to 11%. Interanalyzer correlation found correlation coefficients (r2) ranging from 0.927 to 0.997. Our reference values were consistent with those provided by the manufacturer. No robust correlation was found with conventional coagulation tests. The correlation with the TEG5000 was excellent with r2 ranging from 0.75 to 0.92. Resistance to stress conditions was excellent.
Conclusion: The VCM analyzer is a reliable, easy-to-use instrument that correlates well with the TEG5000. Despite some logistical constraints, the results suggest that it can be used in austere environments. Further studies are required before its implementation.
Keywords: Thromboelastography; blood transfusion; early goal‐directed therapy; hemorrhage; hemostasis.
© 2024 AABB.
References
REFERENCES
-
- Eastridge BJ, Holcomb JB, Shackelford S. Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury. Transfusion (Paris). 2019;59(S2):1423–1428.
-
- Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, et al. Trauma‐induced coagulopathy. Nat Rev Dis Primer. 2021;7(1):1–23.
-
- Kornblith LZ, Moore HB, Cohen MJ. Trauma‐induced coagulopathy: the past, present, and future. J Thromb Haemost. 2019;17(6):852–862.
-
- Meyer DE, Vincent LE, Fox EE, O'Keeffe T, Inaba K, Bulger E, et al. Every minute counts: time to delivery of initial massive transfusion cooler and its impact on mortality. J Trauma Acute Care Surg. 2017;83(1):19–24.
-
- Bunch CM, Berquist M, Ansari A, McCoy ML, Langford JH, Brenner TJ, et al. The choice between plasma‐based common coagulation tests and cell‐based viscoelastic tests in monitoring hemostatic competence: not an either‐or proposition. Semin Thromb Hemost. 2022 Oct;48(7):769–784.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
